Gadovist 1.0 (gadobutrol) is now also indicated in adults and children including full-term newborns for: contrast enhancement in whole body MRI including head and neck region, thoracic space, breast, abdomen (pancreas, liver and spleen), pelvis (prostate, bladder and uterus), retroperitoneal space (kidney), extremities and musculoskeletal system; and contrast enhancement in cardiac MRI including assessment of rest and pharmacological stress perfusion and delayed enhancement.
Xiaflex (collagenase clostridium histolyticum) is now also indicated for: the treatment of adult men with Peyronie’s disease with a palpable plaque and curvature deformity of at least 30 degrees at the start of therapy.
Copyright © MIMS Australia Pty Ltd. All rights reserved.
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629